Modafiendz

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Modafiendz
Clinical data
Other namesN-Methyl-4,4-difluoromodafinil; Methyldifluoromodafinil; N-Methylbisfluoromodafinil; Bisfluoro-N-methylmodafinil; Methylflmodafinil
Identifiers
  • 2-[bis(4-fluorophenyl)methylsulfinyl]-N-methylacetamide
CAS Number
PubChem CID
ChemSpider
UNII
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H15F2NO2S
Molar mass323.36 g·mol−1
3D model (JSmol)
  • CNC(=O)CS(=O)C(C1=CC=C(C=C1)F)C2=CC=C(C=C2)F
  • InChI=1S/C16H15F2NO2S/c1-19-15(20)10-22(21)16(11-2-6-13(17)7-3-11)12-4-8-14(18)9-5-12/h2-9,16H,10H2,1H3,(H,19,20)
  • Key:MQZWTCIUDSDFCQ-UHFFFAOYSA-N

Modafiendz, also known as N-methyl-4,4-difluoromodafinil or as N-methylbisfluoromodafinil, is a wakefulness-promoting agent related to modafinil that was never marketed.[1][2][3] It is sold online and used non-medically as a nootropic (cognitive enhancer).[1][2][3]

Modafiendz is the bis-fluoro and N-methylated derivative of modafinil as well as the N-methyl analogue of flmodafinil (CRL-40,940; bisfluoromodafinil) and fladrafinil (CRL-40,941; bisfluoroadrafinil).[1][2]

Modafinil and its analogues have been found to act as selective dopamine reuptake inhibitors and this is thought to be involved in their wakefulness-promoting effects.[2]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ a b c Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ a b c d Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).